Expensive but exceptional! 3 FTSE 250 growth shares that could help you to retire early

These FTSE 100 (INDEXFTSE: UKX) stocks may be expensive but they’re worth every penny, argues Royston Wild.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Dechra Pharmaceuticals (LSE: DPH) is a share fully deserving of a high-rating, I believe. Its forward P/E ratio of 29.8 times, a reading that sails over the widely regarded value watermark of 15 times (or below), is a fair reflection of the immense growth in the animal health category, in my opinion. Medicinal care for animals is increasingly big business as growing global meat demand increases livestock numbers, while the rise in the number of companion animals is also bolstering demand for the products offered by the likes of Dechra.

Latest trading details released this week illustrated this perfectly as revenues at the FTSE 250 firm powered 19.2% higher to £231.4m between July and January.

Through a combination of acquisitions and rising research and development spending — it hiked total spend here by more than four-tenths in that aforementioned six-month period — Dechra is setting itself up to deliver stunning sales growth now and in the future. City analysts agree and are consequently forecasting profits growth of 13% and 14% in the years ending June 2019 and 2020 respectively.

Flying high

SSP Group (LSE: SSPG) is another share from the UK’s second-tier share index carrying a high valuation — in this case a prospective P/E multiple of 24.3 times — because of its brilliant growth credentials.

Earnings at the business, which offers retail and catering services to travellers at hundreds of airports and rail stations the world over, have long boomed by double-digit percentages and the number crunchers are expecting this enviable trend to keep rolling with rises of 11% and 10% touted for the years concluding September 2019 and 2020 respectively.

And forecasts are fully entitled to be so bullish right now. Thanks to a 3.8% rise in net contract gains in the first fiscal quarter, a result that was driven by strong contract wins in North America in particular, revenues shot 7.6% higher year-on-year at constant currencies. And with SSP describing its pipeline of new contracts as “encouraging”, the investment community can be forgiven for expecting more strong progress on the sales front in the near term and thereafter.

Yummy stuff

Greggs (LSE: GRG) is another FTSE 250 company whose great growth pedigree commands a weighty premium, in this example a forward P/E ratio of 22.3 times. It’s a share whose price continues to go from rise strongly, over 42% in the past three months alone, and I’m expecting it to continue going from strength to strength.

The bakery chain’s attractively priced fare is enabling it to sidestep worsening conditions for the British retail sector, as illustrated by the fact that like-for-like sales in company-managed stores leapt 9.6% in the seven weeks to February 15. Jam doughnuts and cups of tea are staples of the domestic diet and by offering them at affordable prices, Greggs is able to keep growing sales.

This is not the only reason to fall in love with the business, though. New product ranges like its much-publicised vegan sausage rolls are going down a storm too, and so it’s no shock that City brokers are forecasting more solid earnings growth, with rises of 13% in 2019 and 7% next year currently pencilled in. It’s a share which, like SSP and Dechra, could make you much richer in the years to come, I believe.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK owns shares of SSP Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »

Investing Articles

Investing £5 a day could help me build a second income of £329 a month!

This Fool explains how £5 a day, or one less takeaway coffee, could help her build a monthly second income…

Read more »